Skip to main content
. 2021 Jul 9;61(4):1589–1599. doi: 10.1093/rheumatology/keab522

Fig. 3.


Fig. 3

Forest plot of risk of major adverse cardiac events by therapeutic drug class in sensitivity analyses

*New users defined by lack of treatment in the 5 years preceding the index date. **Adjusted on conventional synthetic DMARDs, NSAIDs, prednisone, age, sex, chronic renal failure, chronic obstructive pulmonary disease, diabetes, hypertension, dyslipidaemia, antiplatelet agent and deprivation index. HRw: weighted hazard ratio; MACE: major adverse cardiac event.